Nanoparticles for photoimmune therapy comprising photosensitizer and adjuvant, and usage thereof

Abstract

The present invention relates to nanoparticles, a pharmaceutical composition comprising same for preventing or treating cancer or a cell hyperplasia disorder, and the like, the nanoparticles comprising: a methylene blue-organic acid complex; a cationic adjuvant-organic acid complex; and an amphiphilic polymer, wherein the nanoparticles are an agent having excellent drug properties and permeability, and are composed only of substances in clinical use so as to have low barriers to clinical entry and high potential for commercialization. In addition, the nanoparticles make it possible to have photodynamic therapy and immunotherapy, simultaneously, and thus may be utilized in the field of preventing, ameliorating, or treating cancer or a cell hyperplasia disorder.

Dependencies are inferred from the claim text.